AIDDISON Description
AIDDISON™ is an innovative drug discovery software that harnesses the capabilities of artificial intelligence (AI), machine learning (ML), and advanced 3D computer-aided drug design (CADD) techniques, serving as an essential resource for medicinal chemistry applications. This comprehensive platform streamlines both ligand-based and structure-based drug design, effectively merging all components necessary for virtual screening while also facilitating in-silico lead discovery and optimization processes. By leveraging these cutting-edge technologies, AIDDISON™ significantly enhances the efficiency and effectiveness of the drug development pipeline.
AIDDISON Alternatives
StackAI is an enterprise AI automation platform that allows organizations to build end-to-end internal tools and processes with AI agents. It ensures every workflow is secure, compliant, and governed, so teams can automate complex processes without heavy engineering.
With a visual workflow builder and multi-agent orchestration, StackAI enables full automation from knowledge retrieval to approvals and reporting. Enterprise data sources like SharePoint, Confluence, Notion, Google Drive, and internal databases can be connected with versioning, citations, and access controls to protect sensitive information.
AI agents can be deployed as chat assistants, advanced forms, or APIs integrated into Slack, Teams, Salesforce, HubSpot, ServiceNow, or custom apps.
Security is built in with SSO (Okta, Azure AD, Google), RBAC, audit logs, PII masking, and data residency. Analytics and cost governance let teams track performance, while evaluations and guardrails ensure reliability before production.
StackAI also offers model flexibility, routing tasks across OpenAI, Anthropic, Google, or local LLMs with fine-grained controls for accuracy.
A template library accelerates adoption with ready-to-use workflows like Contract Analyzer, Support Desk AI Assistant, RFP Response Builder, and Investment Memo Generator.
By consolidating fragmented processes into secure, AI-powered workflows, StackAI reduces manual work, speeds decision-making, and empowers teams to build trusted automation at scale.
Learn more
Meet Healthee—your intelligent healthcare navigation platform.
Healthee takes the guesswork out of healthcare by delivering clear, personalized answers to employees’ healthcare and benefits questions—instantly. Employees can seamlessly navigate their existing health plans with on-demand guidance, all in one intuitive, mobile-first experience.
Powered by Zoe, Healthee’s AI-powered Personal Health Assistant, employees receive tailored insights into coverage, costs, and care options—helping them make smarter decisions that reduce unnecessary healthcare spend.
Healthee also simplifies open enrollment with easy-to-use plan comparison tools, guiding employees to the plans that best fit their needs and expected usage. This drives better plan selection, fewer surprises, and meaningful cost savings for both employees and employers.
For HR teams, Healthee reduces administrative burden by delivering fast, accurate benefits support without changing existing plans. For finance leaders, claims analytics and cost insights provide visibility into utilization trends and key cost drivers, empowering CFOs to optimize plan design and control rising healthcare costs.
The result: confident employees, healthier organizations, and a more cost-effective benefits strategy—right at your fingertips.
Built for benefits managers and HR leaders, Healthee serves as a total benefits administration solution that consolidates 50+ point solutions into one intelligent hub. From FSA and HSA guidance to mental health navigation, telemedicine, and EAP access, Healthee connects every benefit in one place—increasing utilization, reducing cost-per-claim, and eliminating benefits fragmentation. Real-time analytics surface which benefits are underused so managers can reallocate budget strategical
Learn more
Recursion
Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.
Learn more
Atomwise
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Learn more
Pricing
Free Trial:
Yes
Integrations
No Integrations at this time
Company Details
Company:
Merck KGaA
Year Founded:
1668
Headquarters:
Germany
Website:
www.sigmaaldrich.com/US/en/services/software-and-digital-platforms/aiddison-ai-powered-drug-discovery
Media
Recommended Products
Demo Series - Small Business Backup By Veeam
Watch this on-demand demo series and learn how to protect your Microsoft 365 data with clear, simple, actionable steps that are easy to implement for businesses of all sizes.
Product Details
Platforms
Web-Based
Types of Training
Training Docs
Live Training (Online)
Webinars
In Person
Training Videos
Customer Support
Business Hours
Online Support
AIDDISON Features and Options
AIDDISON User Reviews
Write a Review- Previous
- Next
